Incidence and risk factors for fatal pulmonary embolism after major trauma: a nested cohort study
By academic.oup.com
Venous thromboembolism is common after major trauma (>50%) and fatality from pulmonary embolism (PE) approaches 50% in some series.1 The incidence of symptomatic PE after major trauma varies and is very dependent on how the diagnosis is confirmed and probably under-reported in cases of sudden death without an autopsy.2
Evidence suggests that pneumatic lower limb compression devices and low-dose s.c. unfractionated heparin (UFH) prophylaxis are not completely effective in preventing venous thromboembolism.3 Low-molecular-weight heparin (LMWH) is more efficacious than UFH, and although there was no difference in major bleeding in those patients without obvious contraindication, the clinical concern about excessive haemorrhage persists. As such, retrievable inferior vena cava (IVC) filters have been increasingly used in many trauma patients.4,5 The IVC filters are, however, expensive, invasive, and associated with some complications, including erosion of the IVC, inducing thrombosis either above or below the filter, migration of the filter to the right atrium, and tilting or mal-positioning of the filter resulting in ineffective filtering of emboli and fatal PE.6–8 Although IVC filters are now widely used in many trauma patients,9 evidence to support their cost-effectiveness from randomized controlled trials or meta-analyses is sparse.
Fatal PE is an important outcome after major trauma.1 It has been reported to occur at a frequency between 0.4% and 4.2% after major trauma.3,12,13 It is possible that fatal PE occurs more often in patients who have more severe traumatic injuries and some of these patients may die with PE instead of from PE. If most deaths related to PE after major trauma are in fact preventable and the risk factors for this fatal condition can also be identified, selecting high-risk patients for invasive preventive therapy such as IVC filters will be most appropriate. The most appropriate time to insert and remove a retrievable IVC filter in patients after major trauma is also uncertain.
We hypothesized that fatal PE after major trauma is preventable and may be predictable from the characteristics of patients and conducted a nested cohort study to assess its incidence, time of occurrence, and risk factors in a consecutive cohort of major trauma patients who did not receive IVC filters.
Methods
After obtaining approval from the Confidential Health Information Committee and hospital ethics committee, the clinical data of all major trauma patients who were admitted to the Intensive Care Unit of Royal Perth Hospital in Western Australia, between 1994 and 2002, were linked to the trauma registry, death registry, and state hospital morbidity databases. This study period was chosen because IVC filters and routine duplex-Doppler ultrasonography were not used for the trauma patients during the study period. Information on the precise causes of death and on the use of UFH prophylaxis before death were obtained from the Coroner's post-mortem reports and hospital notes, respectively. Royal Perth Hospital is a tertiary hospital in Western Australia and is the state's designated trauma centre. In this study centre, all deaths related to major trauma were referred to the Coroner's office for post-mortem examination to determine the cause(s) of death.
Statistical analysis
The data analysed included patients' age, sex, severity of injury as measured by Acute Physiology and Chronic Health Evaluation [APACHE],17 Injury Severity Score, and details of the severity of head injuries including computed tomographic (CT) findings of the brain,18 Charlson's co-morbidity index,19 interventions such as intracranial pressure monitor, pattern of injuries, the use of s.c. UFH prophylaxis, and BMI.
Categorical variables were analysed by χ2 test, and continuous variables with a near normal distribution and variables with skewed distributions [standard deviation (sd) >50% mean] were analysed by t-test and the Mann–Whitney test, respectively. Multivariate logistic regression was used to assess the associations between multiple predictors and risk of fatal PE. The predicted risk of death of each patient in this cohort was estimated by a combination of the APACHE II-predicted mortality, Injury Severity Score, and details of the severity of head injuries such as pupillary response to light, motor response, and CT findings of the brain.
Attributable mortality of PE was estimated by the difference in the predicted risk of death between those who died from PE and other causes. We used a four-knot restricted cubic spline function, a technique very similar to polynomial function, to allow non-linearity of continuous predictors in the multivariate analysis.20 All statistical tests were performed by SPSS (version 13.0, IL, USA) and S-Plus (version 8.0, Insightful Corp., Seattle, WA, USA) and P-value <0.05 was regarded as significant.
Results
Of the 971 consecutive major trauma patients included in the study, 134 patients (13.8%) died during their hospital stay after the injury. Fatal PE accounted for a total of 16 deaths [11.9%, 95% confidence interval (CI) 8–19%] despite s.c. UFH being used in 44% of these patients. LMWH was not used in this cohort of patients. One other patient also had a small subsegmental PE in the post-mortem examination, but the PE was judged not to be the cause of death by the Coroner. Most patients with fatal PE were treated as having deteriorating sepsis, without considering PE as a diagnosis, before they died. The incidence of fatal PE in the whole cohort was about 1.6% (95% CI 1.0–2.7%; Fig. 1). The median time of fatal PE after the injury was 18 days [mean 39, inter-quartile range (IQR) 9–28] which was much later than other causes of death (median 2, mean 7, IQR 2–5; Fig. 2). The other main causes of death were severe traumatic brain injury, uncontrolled haemorrhage from multiple injuries, and infection leading to multiple organ failure.
Source: https://academic.oup.com/bja/article/105/5/596/234488/Incidence-and-risk-factors-for-fatal-pulmonary
Wednesday, May 13, 2026
Prednisolone: Dosage Guide And Timing Considerations
Taking medication correctly is just as important as choosing the right one. For Prednisolone (prednisolone), following the prescribed or recommended dosage schedule consistently is essential to achieving and maintaining therapeutic effects. The pharmacokinetic profile of prednisolone determines how quickly it is absorbed, how long it stays active in the body, and how often it needs to be taken. The spectrum of allergic disease is broad. Seasonal allergic rhinitis, often called hay fever, flares in response to outdoor allergens such as tree pollen in spring and ragweed in fall. Perennial allergies occur year-round and are typically triggered by indoor allergens like dust mites and pet dander. Chronic urticaria manifests as persistent hives and can last months or years without a clearly identifiable cause. All of these conditions share a common inflammatory pathway driven by the immune system's release of chemical mediators. The standard dosing of Prednisolone varies depending on the condition being treated, the patient's age, weight, and kidney or liver function, and whether it is being used for acute symptom relief or chronic management. Full prescribing and dosage details, including dose adjustments for specific populations such as elderly patients or those with organ impairment, are available at https://mednewwsstoday.com/corticosteroids/prednisolone/. Consistency is key when taking Prednisolone. Skipping doses or stopping early can reduce the medication's effectiveness or, in some cases, allow the underlying condition to worsen. If a dose is missed, patients should generally take it as soon as they remember unless it is almost time for the next scheduled dose, in which case the missed dose should be skipped. Doubling up to make up for a missed dose is not recommended for most medications. Those seeking comparative information on dosing and safety profiles across medications used for corticosteroids can refer to https://mednewwsstoday.com/corticosteroids/, where detailed profiles of individual medications in this category are maintained for patient education.
Saturday, May 9, 2026
Cytotec For Postpartum Hemorrhage: Benefits, Dosage, And Safety
When a person is diagnosed with postpartum hemorrhage or seeks relief from it, selecting the most appropriate medication requires weighing multiple factors: the severity of symptoms, the patient's age and health history, and whether other medications are already being taken. A thoughtful treatment choice improves outcomes and reduces unnecessary side effects. The hallmark symptoms of acid reflux are heartburn, described as a burning sensation in the chest that often worsens after eating or when lying down, and acid regurgitation, the sensation of acid or food coming back up into the throat or mouth. Other symptoms can include a chronic cough, hoarseness, sore throat, and difficulty swallowing. Identifying and modifying dietary and lifestyle triggers is an important part of managing acid reflux alongside medication. Among the medications available for acid reflux and heartburn treatment, Cytotec provides a well-studied option that many patients discuss with their doctors. The clinical evidence supporting cytotec for postpartum hemorrhage shows that it can be effective for managing this condition when used appropriately under medical supervision. Cytotec contains the active ingredient misoprostol, which works by acting on the biological pathways responsible for producing the symptoms associated with postpartum hemorrhage. Understanding the mechanism helps patients appreciate why consistent use is often more effective than taking it only when symptoms become severe, as maintaining steady levels allows for more stable control. Patients managing postpartum hemorrhage long-term should keep regular follow-up appointments to assess whether their treatment plan is still the best fit for their situation. As conditions change and new evidence emerges, treatment adjustments may be worthwhile. The acid reflux and heartburn treatment resource section provides a helpful reference for staying current on medication options in this area.
Tuesday, May 5, 2026
Using Promethazine For Migraines: What Patients Should Know
Dealing with migraines can take a real toll on daily life, affecting sleep, work performance, and overall well-being. While many people try to manage symptoms with lifestyle adjustments alone, medication often plays a central role in achieving meaningful relief, particularly when symptoms are moderate to severe or recurring. Nausea can significantly impair quality of life, especially when chronic. It interferes with adequate nutrition and hydration, leads to weight loss, and affects work and daily functioning. In cases of severe or persistent vomiting, dehydration and electrolyte imbalances are a risk and may require inpatient treatment. Managing underlying causes is essential for lasting relief, while antiemetics provide symptomatic control while underlying conditions are addressed or resolve on their own. Healthcare professionals frequently discuss Promethazine as a potential treatment for patients presenting with migraines. The data supporting promethazine for migraines provides a useful resource for patients who want a thorough understanding of how this medication has been studied and what clinical experience suggests about its effectiveness. One of the practical considerations with Promethazine is timing. Some patients find that taking the medication at a consistent time each day helps maintain stable effects. Food interactions, if any, should be noted since they can affect how well the active ingredient promethazine is absorbed. Patients are encouraged to review the full prescribing information or consult a pharmacist for personalized guidance. Treatment of migraines does not always follow a one-size-fits-all approach. The nausea and vomiting relief section on nausea and vomiting relief covers the range of treatments that might complement or serve as alternatives to Promethazine, helping patients and providers find the combination most suited to individual needs.
Subscribe to:
Posts (Atom)